Capricor Therapeutics (CAPR) Debt to Equity (2010 - 2024)
Capricor Therapeutics (CAPR) recorded quarterly Debt to Equity of $0.05 in Q3 2024, down 83.15% quarter-over-quarter from $0.29 in Q2 2024, and up 102.62% on a YoY basis from $0.02 in Q4 2023.
Capricor Therapeutics (CAPR) Debt to Equity (2010 - 2024) Analysis & Trends
Capricor Therapeutics' Debt to Equity history runs 15 years deep, the most recent figure standing at $0.05 for Q3 2024.
- In Q3 2024, Debt to Equity rose 102.62% year-over-year to $0.05; the TTM figure through Sep 2024 stood at $0.05 (up 102.62% YoY), while the FY2023 annual figure was $0.15, down 49.2% from the prior year.
- Debt to Equity was $0.05 for Q3 2024 at Capricor Therapeutics, down from $0.29 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $1.24 in Q2 2023 to a low of -$1.89 in Q3 2023.
- Historically, Debt to Equity has averaged $0.13 across 5 years, with a median of $0.15 in 2022.
- The sharpest annual moves came in 2021 and 2023: Debt to Equity surged 1696.34% in 2021, then sank 941.96% in 2023.
- A 5-year view of Debt to Equity shows it stood at $0.12 in 2020, then grew by 5.86% to $0.13 in 2021, then jumped by 131.99% to $0.29 in 2022, then slumped by 49.2% to $0.15 in 2023, then tumbled by 66.89% to $0.05 in 2024.
- The last three Debt to Equity figures came in at $0.05 (Q3 2024), $0.29 (Q2 2024), and $0.18 (Q1 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 0.32 |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Capricor Therapeutics | 1.53 Bn | 1.26 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 0.05 |
| Jun 30, 2024 | 0.29 |
| Mar 31, 2024 | 0.18 |
| Dec 31, 2023 | 0.15 |
| Sep 30, 2023 | -1.89 |
| Jun 30, 2023 | 1.24 |
| Mar 31, 2023 | 0.55 |
| Dec 31, 2022 | 0.29 |
| Sep 30, 2022 | 0.22 |
| Jun 30, 2022 | 0.19 |
| Mar 31, 2022 | 0.16 |
| Dec 31, 2021 | 0.13 |
| Jun 30, 2021 | 0.10 |
| Mar 31, 2021 | 0.09 |
| Dec 31, 2020 | 0.12 |
| Sep 30, 2020 | 0.11 |
| Jun 30, 2020 | 0.01 |
| Mar 31, 2020 | 0.35 |
| Dec 31, 2019 | 0.49 |
| Sep 30, 2019 | 0.95 |